jetcityimage Shares of WW International (NASDAQ:WW) and LifeMD (NASDAQ:LFMD) fell Thursday after Eli Lilly (LLY) launched LillyDirect, a website to offer telehealth access and home delivery of drugs for conditions such as obesity and diabetes. WW International (WW) and LifeMD (LFMD), which also operate similar offerings, dropped ~15% and ~29% in reaction, respectively, while telehealth platform Hims & Hers Health (NYSE:HIMS) lost ~3%.

周四，礼来公司（Eli Lilly）推出LillyDirect网站，为肥胖和糖尿病等疾病提供远程医疗服务和家庭递送药物，jetcityimage在WW International（纳斯达克：WW）和LifeMD（纳斯达克：LFMD）的股价下跌。同样经营类似产品的WW International（WW）和LifeMD（LFMD）的反应分别下降了约15%和约29%，而远程保健平台Hims＆Hers Health（纽约证券交易所：Hims）则下降了约3%。

'LillyDirect offers more choices in how and where people access healthcare, including a convenient home delivery option to fill Lilly medicines they have been prescribed,' LLY CEO David Ricks remarked. Eli Lilly's (LLY) newly-approved weight loss medication, Zepbound, will also be available on the new website less than two months after the FDA approved the popular obesity therapy amid strong demand for its sister drug, Mounjaro.

LLY首席执行官大卫·里克斯（DavidRicks）表示：“LillyDirect在人们如何以及在哪里获得医疗保健方面提供了更多选择，包括方便的家庭递送选项，以填充他们开具的礼来药物。”。礼来公司（LLY）新批准的减肥药Zepbound也将在新网站上发布，因为FDA批准了受欢迎的肥胖疗法，而对其姊妹药Mounjaro的需求旺盛。

In 2023, WW International (WW) moved to benefit from surging demand for obesity drugs with its $106M purchase of telehealth provider Sequence in October. More on Him & Hers, LifeMD, etc. Hims & Hers Health: Faultless, Ready To Go Higher Hims & Hers: New Weight Loss Category Is A Prescription For Explosive Growth And Upward Revisions Hims & Hers Health: Promising Catalysts To Drive Stock Higher Employers seeking virtual care to manage demand for weight loss drugs: report LifeMD price surges 17%, Medifast invests $20M .

2023年，WW International（WW）于10月斥资1.06亿美元收购了远程保健提供商Sequence，从而受益于肥胖药物需求的激增。关于他和她的，LifeMD等的更多信息。他和她的健康：完美无瑕，随时准备提高他的和她的健康：新的减肥类别是爆炸性增长和向上修订的处方。他和她的健康：有希望推动股票上涨的催化剂寻求虚拟护理来管理减肥药物的需求：报告LifeMD价格飙升17%，Medifast投资2000万美元。